Calling all Clinical Phase I Outsourcing Professionals!

Posted:
4
February 2007

Do You Outsource Phase I Clinical Trials?Outsourcing remains a critical aspect of clinical development. All major drug development projects rely on one or more partners to aid the drug development process. The 9th Annual Phase I Clinical Trials conference on 19-20 February at Olympia Conference Centre, London will highlight the following:

  • A timely update on the guidance for first man studies � the revision of EMEA guidelines
  • What are the challenges and priorities over the next five years for the MHRA
  • How to manage potentially 'high risk' complex molecules. Tegenero: a case study
  • The challenges of conducting phase I studies in patients

Get the answers you need to all your outsourcing questions and meet the team from Richmond Pharmacology, the Early Phase CRO that can help you achieve your goals.Wednesday 20 February 2008 at 2pm, Dr. Jörg Täubel MFPM, MD, Managing Director, Richmond Pharmacology, invites you to discuss "Why carry out Phase 1 Trials in the UK, focussing primarily on the regulatory implications of conducting Phase 1 studies in the UK".We look forward to meeting you at the Congress. Visit the Richmond Pharmacology team at Stand No 3 to discuss your Early Phase outsourcing requirements.Exhibitor DiscountAs exhibitors we are delighted to offer you a discount of 25% off the first person and 15% off each additional person after that if you would like to attend the conference. Please call Angela Davie, Business Development Manager, on 020 8664 5200 or book direct quoting our VIP CODE - TT30 and booking code TT30Spex.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.
Read more

A new era for UK-Japanese scientific relations

March 23, 2021
Dr Taubel uses his experience of conducting more than 60 Japanese bridging studies to explain why the deal is of strategic importance to the UK and highlights the scientific requirements for conducting successful Japanese trials abroad
Read more

Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

February 3, 2021
Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London
Read more